Sagoh

Beyond the Surface: The Critical Imperative of Advanced Wound Diagnostics

• Genomics and Precision Medicine

Beyond the Surface: The Critical Imperative of Advanced Wound Diagnostics

Sagoh June 13, 2026

In the landscape of modern medicine, the wound is often treated as a peripheral concern—a byproduct of...

Read More Read more about Beyond the Surface: The Critical Imperative of Advanced Wound Diagnostics

From Isolation to Empowerment: How Shanti’s PACT Program Transformed Edith’s Life

• Integrative Oncology and Holistic Care

From Isolation to Empowerment: How Shanti’s PACT Program Transformed Edith’s Life

Sagoh June 6, 2026

Introduction: A Sanctuary Reclaimed When you first meet Edith, you are immediately struck by a sense of...

Read More Read more about From Isolation to Empowerment: How Shanti’s PACT Program Transformed Edith’s Life

The Healing Kitchen: How Anti-Inflammatory Nutrition Empowers Breast Cancer Survivors

• Survivorship and Post-Treatment

The Healing Kitchen: How Anti-Inflammatory Nutrition Empowers Breast Cancer Survivors

Sagoh June 5, 2026 0

By Shelley Loving, CNE, CPC, INHC For many, the kitchen is the heart of the home, but...

Read More Read more about The Healing Kitchen: How Anti-Inflammatory Nutrition Empowers Breast Cancer Survivors

Redefining the Standard of Care: A Deep Dive into the EMBARK Trial and the Evolution of Prostate Cancer Treatment

• Clinical Oncology Education

Redefining the Standard of Care: A Deep Dive into the EMBARK Trial and the Evolution of Prostate Cancer Treatment

Sagoh June 4, 2026 0

The landscape of prostate cancer management has undergone a seismic shift, driven by the landmark findings of...

Read More Read more about Redefining the Standard of Care: A Deep Dive into the EMBARK Trial and the Evolution of Prostate Cancer Treatment

ResMed Bolsters Sleep Medicine Portfolio with $340M Acquisition of Noctrix Health

• Treatment Innovations

ResMed Bolsters Sleep Medicine Portfolio with $340M Acquisition of Noctrix Health

Sagoh June 4, 2026 0

In a significant consolidation within the sleep technology sector, California-based medical device giant ResMed has announced the...

Read More Read more about ResMed Bolsters Sleep Medicine Portfolio with $340M Acquisition of Noctrix Health

AI’s Collaborative Revolution: Reshaping Breast Cancer Screening with Human-Machine Synergy

• Medical Research and Clinical Trials

AI’s Collaborative Revolution: Reshaping Breast Cancer Screening with Human-Machine Synergy

Sagoh June 3, 2026 0

URBANA-CHAMPAIGN, IL – The future of breast cancer screening is not one where artificial intelligence entirely supplants...

Read More Read more about AI’s Collaborative Revolution: Reshaping Breast Cancer Screening with Human-Machine Synergy

Revolutionizing Pancreatic Cancer Treatment: Daraxonrasib Emerges as a Beacon of Hope

• Medical Research and Clinical Trials

Revolutionizing Pancreatic Cancer Treatment: Daraxonrasib Emerges as a Beacon of Hope

Sagoh June 3, 2026 0

The medical community is abuzz with unprecedented optimism following the presentation of groundbreaking Phase III trial data...

Read More Read more about Revolutionizing Pancreatic Cancer Treatment: Daraxonrasib Emerges as a Beacon of Hope

Crossroads for Fulcrum Therapeutics: Strategic Review Initiated Following FDA-Mandated Halt to Sickle Cell Program

• Chemotherapy and Targeted Therapy

Crossroads for Fulcrum Therapeutics: Strategic Review Initiated Following FDA-Mandated Halt to Sickle Cell Program

Sagoh June 2, 2026 0

In a move that has sent shockwaves through the biotechnology sector, Cambridge, Massachusetts-based Fulcrum Therapeutics announced on...

Read More Read more about Crossroads for Fulcrum Therapeutics: Strategic Review Initiated Following FDA-Mandated Halt to Sickle Cell Program

Precision Medicine Redefines High-Risk Breast Cancer Care: The OPTIMA Trial and the End of Mandatory Chemotherapy

• Patient Advocacy and Support

Precision Medicine Redefines High-Risk Breast Cancer Care: The OPTIMA Trial and the End of Mandatory Chemotherapy

Sagoh June 2, 2026 0

The landscape of oncology is undergoing a seismic shift, moving away from the "more is better" philosophy...

Read More Read more about Precision Medicine Redefines High-Risk Breast Cancer Care: The OPTIMA Trial and the End of Mandatory Chemotherapy

Blood Cancer Breakthroughs Dominate ASCO 2026: Promising Data Emerges for CLL, Myelofibrosis, and Rare Malignancies

• Medical Research and Clinical Trials

Blood Cancer Breakthroughs Dominate ASCO 2026: Promising Data Emerges for CLL, Myelofibrosis, and Rare Malignancies

Sagoh June 2, 2026 0

Chicago, IL – The 2026 American Society of Clinical Oncology (ASCO) annual meeting, a cornerstone event for...

Read More Read more about Blood Cancer Breakthroughs Dominate ASCO 2026: Promising Data Emerges for CLL, Myelofibrosis, and Rare Malignancies